4.7 Article

Predictors of Progression and Mortality in Patients with Prevalent Rheumatoid Arthritis and Interstitial Lung Disease: A Prospective Cohort Study

Related references

Note: Only part of the references are listed.
Article Rheumatology

Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis

Natalia Mena-Vazquez et al.

Summary: The study found that most patients with RA-ILD receiving DMARD treatment were able to stabilize lung function and control inflammatory activity well. Non-anti-TNF DMARDs reduce the risk of worsening lung disease in 90% of patients, while RA inflammatory activity and smoking are associated with worsening.

CLINICAL RHEUMATOLOGY (2021)

Article Rheumatology

Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study

Else Helene Ibfelt et al.

Summary: Patients with rheumatoid arthritis have a higher risk of ILD compared to the general population, but there is no additional risk associated with MTX treatment.

RHEUMATOLOGY (2021)

Article Rheumatology

Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK study

Clive A. Kelly et al.

Summary: The study showed that the prognosis of patients with RA-ILD has improved over a 25-year period, with an increase in all cause (respiratory) mortality compared to controls. Use of specific drugs like anti-TNF therapy may increase the risk of death, while rituximab or mycophenolate could lower mortality rates. Patients receiving rituximab as their first biologic had better survival rates compared to those receiving anti-TNF agents.

RHEUMATOLOGY (2021)

Article Medicine, General & Internal

Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study

Andreina Manfredi et al.

INTERNAL MEDICINE JOURNAL (2020)

Article Multidisciplinary Sciences

A prospective study of lung disease in a cohort of early rheumatoid arthritis patients

A. Robles-Perez et al.

SCIENTIFIC REPORTS (2020)

Article Medicine, General & Internal

Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis

Ji Ae Yang et al.

KOREAN JOURNAL OF INTERNAL MEDICINE (2019)

Review Critical Care Medicine

Pulmonary Complications of Rheumatoid Arthritis

Hamish Farquhar et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Rheumatology

Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients

Carlos Fernandez-Diaz et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)

Review Rheumatology

The Lung in Rheumatoid Arthritis Focus on Interstitial Lung Disease

Paolo Spagnolo et al.

ARTHRITIS & RHEUMATOLOGY (2018)

Review Medicine, General & Internal

Cyclophosphamide for connective tissue disease-associated interstitial lung disease

Hayley Barnes et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)

Article Rheumatology

Patterns of interstitial lung disease and mortality in rheumatoid arthritis

Jorge A. Zamora-Legoff et al.

RHEUMATOLOGY (2017)

Article Rheumatology

Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis

Dam Kim et al.

RHEUMATOLOGY INTERNATIONAL (2017)

Article Rheumatology

Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease

Jorge A. Zamora-Legoff et al.

ARTHRITIS & RHEUMATOLOGY (2017)

Article Respiratory System

Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease

Joshua J. Solomon et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Article Cardiac & Cardiovascular Systems

Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease

Justin M. Oldham et al.

RESPIRATORY MEDICINE (2016)

Article Rheumatology

Methotrexate and Lung Disease in Rheumatoid Arthritis

Richard Conway et al.

ARTHRITIS & RHEUMATOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis

Shunsuke Mori et al.

RESPIRATORY MEDICINE (2012)

Article Respiratory System

Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome

Y. Tsuchiya et al.

EUROPEAN RESPIRATORY JOURNAL (2011)

Review Rheumatology

Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases

Roberto Perez-Alvarez et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)

Article Respiratory System

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease

E. J. Kim et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

Letter Medicine, General & Internal

Rheumatoid arthritis interstitial lung disease: Mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug

Lcslcy Ann Saketkoo et al.

ARCHIVES OF INTERNAL MEDICINE (2008)

Review Rheumatology

Lung disease in rheumatoid arthritis

Carlotta Nannini et al.

CURRENT OPINION IN RHEUMATOLOGY (2008)